Government to sign off on CF drug deal next month

Negotiations between HSE and manufacturer Vertex over the drug's price enter final phase

12th March, 2017

The government expects to sign off on the purchase of life-changing cystic fibrosis drug Orkambi next month.

Protracted negotiations between the HSE and manufacturer Vertex over the price of the drug have entered the final phase, with a ten-year deal that encompasses other cystic fibrosis treatments like Kalydeco envisaged.

The exact price the state will pay for Orkambi is unclear, but it will be lower than the €159,000 per patient, per year rejected by the...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Nadine O’Regan: Fishing for compliments at our own funerals

Emer McLysaght: Take it or leave it, Father’s Day is not an issue

Columnists Emer McLysaght 15 hours ago

Analysis: Moral hazard at the heart of public health leaders’ reluctance to begin use of rapid antigen testing

Coronavirus Daniel Murray 15 hours ago

Elaine Byrne: What structural defect means taxpayers always carry the can?

Politics Elaine Byrne 15 hours ago